跳至主要内容
临床试验/CTRI/2014/07/004756
CTRI/2014/07/004756已完成2/3 期

A clinical study to evaluate efficacy and safety of Appetol syrup in children suffering from non-specific anorexia

ARJUN HEALTHCARE1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年4月8日最近更新:

试验速览

阶段
2/3 期
状态
已完成
入组人数
50
试验地点
1
主要终点
To evaluate efficacy of Appetol syrup in children suffering from non-specific anorexia by assessing SNAQ Scale

研究概览

简要总结

This study is an Open Labeled, Non-comparative,Prospective, Single Center Clinical Study to evaluate efficacy and safety ofAppetol syrup in children suffering from non-specific anorexia. The study willbe done in 50 completed patients. Appetol Syrup will be given in a dose of 10ml twice daily after meals for 45 days. After 45 days all the patients will be advisedto stop taking medicine and will be monitored for next 15 days to observerecurrence of symptoms. The trial will be conducted at Department of Balrog, Govt.Ayurvedic College, Tuljapur Road, Osmanabad. Primary outcome will be toevaluate efficacy of Appetol syrup in children suffering from non-specificanorexia by assessing SNAQ Scale. Secondary outcomes will be to evaluateefficacy of Appetol syrup in children suffering from non-specific anorexia byassessing Weight and BMI, Activity level on PAQ-C Scale, Abdominal pain/cramps,abdominal distension, flatulence, constipation, nausea, vomiting, Overallimprovement by Physician and Patient’s LAR at the end of the study, acceptabilityof drug, Drowsiness or sedation, Adverse events and drug tolerability bypatient’s LAR and physician at the end of the study

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
5.00 Year(s) 至 9.00 Year(s)(—)
性别
All

入选标准

  • 1 The informed consent document must be read signed and dated by subjects legally authorized representative before conducting any study procedures or examination 2 Males and females between 5 to 9 years of age 3.Subjects suffering from non specific anorexia 4.Subjects having normal vital parameters.

排除标准

  • 1 Children with SNAQ score less than or equal to 14 2 Children with chronic illnesses congenital abnormalities 3 Subject who is on other appetite stimulants sedatives narcotics and steroidal drugs 4 Subjects who have received treatment another investigational agent within last thirty days from Screening Visit 5 Subjects who have received chemotherapy or radiation therapy within the past 5 years 6 Subjects on systemic antibiotics or systemic therapy with cytotoxic drugs 7 Subjects having metabolic and or endocrine disorders 8 Subjects with any type of GI tract disorder including malabsorption syndrome etc 9 Subjects with liver and renal disorders 10 Subjects with known immunological, hematologic disorders or malignancy 11 Subjects having known neurological or psychiatric pathologies 12 Subjects with history of raised levels of cortisol abnormalities of thyroid hormone growth hormone and insulin secretion 13 Subject or LAR refuse to sign informed consent form 14 Subjects having a known hypersensitivity to Appetol Syrup and any of the ingredients of Appetol Syrup.

结局指标

主要结局

To evaluate efficacy of Appetol syrup in children suffering from non-specific anorexia by assessing SNAQ Scale

时间窗: 0 day 15 day 30 day 45 day and 60 day

次要结局

  • 1 Weight and BMI(2 Activity level on PAQ-C Scale)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验